title: Comparison of the effects of ACTH-(1-24), methylprednisolone, aprotinin, and norepinephrine in a model of hemorrhagic shock in rats.
abstract: Rats bled to a severe condition of volume-controlled hemorrhagic shock were randomly assigned to one of the following treatments: (1) saline, 1 ml/kg i.v.; (2) saline, 0.2 ml/kg per min i.v. for 10 min; (3) ACTH-(1-24), 160 micrograms/kg i.v.; 4) methylprednisolone, 40 mg/kg i.v.; (5) methylprednisolone, 80 mg/kg i.v.; (6) aprotinin, 10,000 KIU/kg i.v.; (7) norepinephrine, 5 micrograms/kg per min i.v. for 10 min; (8) norepinephrine, 10 micrograms/kg per min i.v. for 10 min. All rats treated with saline or with either of the two doses of methylprednisolone, and half of the rats treated with aprotinin, died within the subsequent 2 h. On the other hand, rats treated with norepinephrine, at either dose, or with ACTH-(1-24) were all still alive 2 h later, a similar improvement in cardiovascular and respiratory parameters being obtained with the two treatments. The effect of ACTH on mean arterial pressure was however more sustained throughout the observation period. These results further support the potential usefulness of ACTH-(1-24) as first-aid treatment in cases of severe blood losses.
authors.affiliation: Institute of Pharmacology, University of Modena, Italy.
authors.forename: C
authors.initials: C
authors.lastname: Bazzani
authors.forename: A
authors.initials: A
authors.lastname: Balugani
authors.forename: A
authors.initials: A
authors.lastname: Bertolini
authors.forename: S
authors.initials: S
authors.lastname: Guarini
mesh_terms: D000818:Animals; D007611:Aprotinin / Q000627:therapeutic use*; D003366:Cosyntropin / Q000627:therapeutic use*; D005260:Female; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use*; D009638:Norepinephrine / Q000627:therapeutic use*; D051381:Rats; D017208:Rats, Wistar; D012771:Shock, Hemorrhagic / Q000188:drug therapy*; D013997:Time Factors
chemical_list: D003366:Cosyntropin; D007611:Aprotinin; D009638:Norepinephrine; D008775:Methylprednisolone